Related Experiment Video
Updated: Jul 20, 2025
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Senescent Microglia Represent a Subset of Disease-Associated Microglia in P301S Mice
Pei Y Ng1, Cheng Zhang2,3, Hu Li2,3
1Department of Biochemistry and Molecular Biology.
Background:
The existence and contribution of microglia with senescent-like alterations in the pathogenesis of age-related neurodegenerative diseases like Alzheimer's disease (AD) have been suggested in recent years. However, the identification of this distinct microglial population in vivo has proven challenging, largely due to overlaps in the inflammatory phenotype of activated and senescent microglia. Furthermore, attempts at recapitulating senescence in microglia in vitro are limited.
Objective:
To identify and characterize senescent microglia that occur in vivo in an animal model of neurodegeneration driven by pathologic tau.
Methods:
We analyzed the RNA expression patterns of individual microglia from normal mice and the pathogenic tau P301 S PS19 mouse model. We have previously demonstrated that p16-expressing senescent microglia occur in these mice when neurodegeneration has occurred.
Results:
Here we identify a subset of disease-associated microglia with senescent features, notably characterized by the expression of Ccl4. This signature overlaps with established markers of senescence from other cell types.
Conclusion:
Our characterization of senescent microglia can be used to better understand the role of senescent microglia in various age-related contexts, including whether clearance of senescent microglia represents a viable therapeutic option.
Insights
Researchers identified senescent microglia in a mouse model of tau-driven neurodegeneration. These cells, marked by Ccl4 expression, offer insights into aging brain diseases and potential therapeutic targets.
Area of Science:
- Neuroscience
- Immunology
- Aging Research
Background:
- Microglia, immune cells in the brain, may exhibit senescence-like changes contributing to neurodegenerative diseases like Alzheimer's disease.
- Identifying senescent microglia in vivo is difficult due to overlapping inflammatory markers with activated microglia.
- Current in vitro methods for studying microglial senescence are limited.
Purpose of the Study:
- To identify and characterize senescent microglia in a live animal model of tau-driven neurodegeneration.
- To understand the specific markers and roles of senescent microglia in disease pathogenesis.
Main Methods:
- Analysis of RNA expression patterns in individual microglia from wild-type mice and the P301S PS19 mouse model.
- Previous demonstration of p16-expressing senescent microglia in these mice post-neurodegeneration.
Main Results:
- Identification of a specific subset of disease-associated microglia exhibiting senescent features.
- Ccl4 expression is a notable marker for these senescent microglia.
- The identified senescence signature shares similarities with markers found in senescent cells of other types.
Conclusions:
- Characterization of senescent microglia provides a foundation for understanding their role in age-related neurological conditions.
- This research opens avenues for exploring the therapeutic potential of clearing senescent microglia in neurodegenerative diseases.
